These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 7563904

  • 1. [Fluctuation of hepatitis C virus quasispecies with interferon treatment and interferon-resistant variants in hepatitis C virus 1b].
    Sakuma I, Enomoto N, Asahina Y, Kurosaki M, Sato C.
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):930-5. PubMed ID: 7563904
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Genomic changes in the E2/NS1 region of HCV before and after IFN therapy].
    Higashi Y, Kakumu S.
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):923-9. PubMed ID: 7563902
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Novel interferons for treatment of hepatitis C virus.
    Clark V, Nelson DR.
    Clin Liver Dis; 2009 Aug; 13(3):351-63. PubMed ID: 19628153
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hepatitis C virus and the controversial role of the interferon sensitivity determining region in the response to interferon treatment.
    Torres-Puente M, Cuevas JM, Jiménez-Hernández N, Bracho MA, García-Robles I, Carnicer F, del Olmo J, Ortega E, Moya A, González-Candelas F.
    J Med Virol; 2008 Feb; 80(2):247-53. PubMed ID: 18098147
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Does iron reduction improve sustained viral responses to interferon monotherapy in hepatitis C patients? Maybe, but is this the right question?
    Shedlofsky SI.
    Am J Gastroenterol; 2002 May; 97(5):1093-6. PubMed ID: 12014712
    [No Abstract] [Full Text] [Related]

  • 11. [Prediction of interferon therapy outcome by PCR-SSCP analysis of HCV 5' NCR].
    Kurihara C, Katayama K, Fukushi S, Hoshino FB, Ando T, Oya A, Ishiyama N.
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):326-32. PubMed ID: 7563742
    [No Abstract] [Full Text] [Related]

  • 12. Method to detect substitutions in the interferon-sensitivity-determining region of hepatitis C virus 1b for prediction of response to interferon therapy.
    Nishiguchi S, Ueda T, Itoh T, Enomoto M, Tanaka M, Tatsumi N, Fukuda K, Tamori A, Habu D, Takeda T, Otani S, Shiomi S.
    Hepatology; 2001 Jan; 33(1):241-7. PubMed ID: 11124842
    [Abstract] [Full Text] [Related]

  • 13. Future therapies for hepatitis C.
    Pawlotsky JM, Gish RG.
    Antivir Ther; 2006 Jan; 11(4):397-408. PubMed ID: 16856613
    [Abstract] [Full Text] [Related]

  • 14. [HCV-serotype and IFN response].
    Abe K, Miyakawa H, Kako M, Horikoshi K.
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):959-64. PubMed ID: 7563910
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Structural analysis of the PKR-binding region of HCV 1b samples from patients with chronic hepatitis C and the correlation with IFN-sensitivity].
    Gervain J, Czibula A, Simon J, Kalmár T.
    Orv Hetil; 2003 Jun 15; 144(24):1179-84. PubMed ID: 12866147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.